Artificial Peptide Improves the Immunologically Suppressive Microenvironment of Glioblastoma - Application of 7aaRGD
Abstract：Glioblastoma (GBM) is a common malignant tumor in the skull, characterized by high recurrence rate and high disability rate, posing a significant threat to patients' lives [1]. Despite surgery, radiotherapy, and chemotherapy, the 5-year survival rate of patients remains below 5%. Therefore, exploring more effective treatment strategies is crucial.
Machine-generated Keywords：
Publication Date：2025-06-20
Online Publishing Date：2025-08-19(First online date of this platform, not the publication date of the document)
Pages：1( 380 )